Growth Metrics

Omeros (OMER) EPS (Basic) (QoQ) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -50.00%
Dec 31, 2025 402.13%
Sep 30, 2025 -9.30%
Jun 30, 2025 33.85%
Mar 31, 2025 -18.18%
Dec 31, 2024 1.79%
Sep 30, 2024 42.27%
Jun 30, 2024 -53.97%
Mar 31, 2024 -325.00%
Dec 31, 2023 146.67%
Sep 30, 2023 14.29%
Jun 30, 2023 -11.11%
Mar 31, 2023 -130.58%
Dec 31, 2022 336.78%
Sep 30, 2022 -31.82%
Jun 30, 2022 -4.76%
Mar 31, 2022 16.00%
Dec 31, 2021 -108.33%
Sep 30, 2021 55.00%
Jun 30, 2021 1.23%
Mar 31, 2021 -35.00%
Dec 31, 2020 9.09%
Sep 30, 2020 -8.20%
Jun 30, 2020 -15.09%
Mar 31, 2020 8.62%
Dec 31, 2019 -75.76%
Sep 30, 2019 -13.79%
Jun 30, 2019 42.00%
Mar 31, 2019 -4.17%
Dec 31, 2018 40.74%
Sep 30, 2018 -15.71%
Jun 30, 2018 -12.90%
Mar 31, 2018 -82.35%
Dec 31, 2017 -112.50%
Sep 30, 2017 51.52%
Jun 30, 2017 2.94%
Mar 31, 2017 24.44%
Dec 31, 2016 -32.35%
Sep 30, 2016 -6.25%
Jun 30, 2016 40.74%
Mar 31, 2016 -3.85%
Dec 31, 2015 1.89%
Sep 30, 2015 -20.45%
Jun 30, 2015 13.73%
Mar 31, 2015 16.39%
Dec 31, 2014 -12.96%
Sep 30, 2014 -1.89%
Jun 30, 2014 1.85%
Mar 31, 2014 -980.00%
Dec 31, 2013 89.13%
Sep 30, 2013 4.17%
Jun 30, 2013 -20.00%
Mar 31, 2013 -33.33%
Dec 31, 2012 41.18%
Sep 30, 2012 -34.21%
Jun 30, 2012 5.00%
Mar 31, 2012 13.04%
Dec 31, 2011 -58.62%
Sep 30, 2011 -20.83%
Jun 30, 2011 20.00%
Mar 31, 2011 11.76%
Dec 31, 2010 2.86%
Sep 30, 2010 2.78%